Gene · 865
Papers3,690
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,690
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic Analysis of Early Neoplasia in the Breast: Next-Generation Sequencing of Flat Epithelial Atypia and Associated Ductal and Lobular Lesions. | Mod Pathol | 2025 | 40553940 | PubTator, text mining | PubMed |
| A Century of Hypomethylating Agent: A Remarkable Response to Azacitidine Monotherapy for Relapsed Acute Myeloid Leukemia - A Case Report. | Case Rep Oncol | 2025 | 40375888 | PubTator, text mining | PubMed |
| Dynamic clustering of genomics cohorts beyond race, ethnicity-and ancestry. | BMC Med Genomics | 2025 | 40375077 | PubTator, text mining | PubMed |
| Effect of Recombinant Human Amelogenin on the Osteogenic Differentiation Potential of SHED. | Cells | 2025 | 40358181 | PubTator, text mining | PubMed |
| External force to live long and prosper: A passive exercise classification framework. | J Sport Health Sci | 2025 | 40324751 | PubTator, text mining | PubMed |
| CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases. | Diagn Pathol | 2025 | 40307896 | PubTator, text mining | PubMed |
| Refining prognostic tools for luminal breast cancer: genetic insights and comprehensive analysis. | ESMO Open | 2025 | 40305907 | PubTator, text mining | PubMed |
| Anti-lymphoma peptide is inspired by mapping a sequence of four amino acids of KRAI motif as nuclear localization signal of Crlz-1. | Mol Ther Oncol | 2025 | 40093512 | PubTator, text mining | PubMed |
| Clinical and Molecular Predictors of Response and Survival Following Venetoclax Plus Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Study in Chinese Patients. | Cancers (Basel) | 2025 | 40002181 | PubTator, text mining | PubMed |
| Cbfβ: A key regulator in skeletal stem cell differentiation, bone development, and disease. | FASEB J | 2025 | 39996474 | PubTator, text mining | PubMed |
| Mechano-oncogenic cytoskeletal remodeling drives leukemic transformation with mitochondrial vesicle-mediated STING activation. | Cell Stem Cell | 2025 | 39986274 | PubTator, text mining | PubMed |
| Significance of Somatic Mutation Profiling in CML Beyond BCR-ABL: A Retrospective Study of the Indian Population. | Indian J Hematol Blood Transfus | 2025 | 39917513 | PubTator, text mining | PubMed |
| A Cryptic CBFB Deletion-Inversion Expands the Mutational Spectrum of Variants Associated With Cleidocranial Dysplasia. | Clin Genet | 2025 | 39894570 | PubTator, text mining | PubMed |
| The unique structure of the highly conserved PPLP region in HIV-1 Vif is critical for the formation of APOBEC3 recognition interfaces. | mBio | 2025 | 39835817 | PubTator, text mining | PubMed |
| FGFR2-RUNX2 activation: An unexplored therapeutic pathway in luminal breast cancer related to tumor progression. | Int J Cancer | 2025 | 39731522 | PubTator, text mining | PubMed |
| CBFβ Regulates RUNX3 ADP-Ribosylation to Mediate Homologous Recombination Repair. | J Cell Physiol | 2025 | 39696918 | PubTator, text mining | PubMed |
| Characterization of open chromatin sensitive to actin polymerization and identification of core-binding factor subunit beta as mechanosensitive nucleocytoplasmic shuttling protein. | Cytoskeleton (Hoboken) | 2025 | 39239837 | PubTator, text mining | PubMed |
| Prospects for the Protective Mechanisms and Compounds of Bufei Huoxue Capsule against COVID-19 Convalescence: Evaluation of Integrating UHPLC-HRMS Analysis and Network Pharmacology Strategy. | Comb Chem High Throughput Screen | 2025 | 38920066 | PubTator, text mining | PubMed |
| Rapid Screening to Identify Antivirals against Persistent and Acute Coxsackievirus B3 Infection. | ACS Infect Dis | 2024 | 39588796 | PubTator, text mining | PubMed |
Clinical features and long-term outcomes of pediatric patients with de novo acute myeloid leukemia in China with or without specific gene abnormalities: a cohort study of patients treated with BCH-AML 2005. | Hematology | 2024 | 39361146 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/865/papers?page=4